Cerebrolysin vs Normoftal
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: FPE 1070
Cerebrolysin is not a single peptide but a mixture: a preparation of small peptides and free amino acids made by enzymatically breaking down purified porcine (pig) brain protein, manufactured by EVER Neuro Pharma in Austria. It is given by injection and is approved as a prescription drug in dozens of countries for stroke, traumatic brain injury, and dementia, but it is not FDA-approved in the United States. Despite decades of use abroad, the human evidence remains genuinely contested.
Also: Eye Peptide Bioregulator, Retina Peptide
Normoftal is an obscure Russian eye supplement from the Khavinson 'peptide bioregulator' tradition, sold as short peptides meant to support the retina. Be clear-eyed about this one: it is marketed as a dietary supplement, not an approved drug, and the evidence behind it is thin and comes almost entirely from one research lineage. We keep the claims minimal on purpose.
Key Comparison Insights
- Both peptides belong to the Cognitive category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Cerebrolysin | Normoftal |
|---|---|---|
| Category | Cognitive | Cognitive |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | The proposed idea is that Cerebrolysin's small peptides act like the body's own neurotrophic factors, the molecules such as BDNF and NGF that help neurons survive, grow, and form connections. Researchers hypothesize it engages neurotrophic signaling pathways and may protect neurons from injury and support repair after stroke or brain trauma. It is important to be clear that the exact active components and mechanism are not fully defined, partly because it is a complex biological mixture rather than one purified molecule. So the neurotrophic-mimic story is a plausible hypothesis supported by some lab data, not a precisely mapped pathway. | Khavinson's bioregulator theory holds that very short peptides (two to four amino acids) extracted from or modeled on a specific tissue can act as tissue-specific signals, switching gene expression and protein synthesis back toward normal in that organ. Normoftal is the eye/retina version, described as containing a synthesized peptide (marketed as 'AKS-G,' reportedly lysine and glutamic acid) intended to support retinal cells. The proposed mechanism is that the peptide corrects an age- or disease-related 'peptide deficiency' and restores normal cellular function in the retina. This is a hypothesis from one school of research, not a mechanism confirmed by independent molecular studies, and the specific composition claims come from vendors rather than peer-reviewed identification. |
| Common Dosing | 20-32 mg/day subcutaneous (60mg vial reconstituted in 3 mL bac water = 20 mg/mL) Once or twice daily, split doses above 20 mg into AM/PM, gradual titration | 2 capsules 1-2x daily 1-2x daily, before meals |
| Administration | Subcutaneous (research) or intravenous/intramuscular (clinical literature) | Oral capsules, before meals |
| Typical Duration | 8-16 week protocols for research-scale subQ; 10-20 day cycles for clinical IV | 30-day courses, repeat after 2-6 months |
| Best Time to Take | Morning | Morning and evening, before meals |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Cerebrolysin has been tested in many human trials, but the quality and consistency of that evidence is the real story. A Cochrane systematic review on vascular dementia (Cui and colleagues, 2019) concluded that intravenous Cerebrolysin may improve cognition and global function, but cautioned the findings were not definitive because of high risk of bias and heterogeneity across studies. Cochrane reviews of acute ischemic stroke have similarly found insufficient or inconclusive evidence and have flagged a possible signal of increased non-fatal serious adverse events in some analyses. The Alzheimer's Drug Discovery Foundation's Cognitive Vitality review rates the human evidence as mixed and far from conclusive. So while it is a real, widely prescribed drug in many countries, the claim that it reliably improves brain outcomes is not established to Western regulatory standards, and many of the supporting trials come from a narrow set of investigators and sponsors. | Normoftal is sold in Russia as a dietary supplement and is marketed for retinal degeneration, glaucoma, cataracts, diabetic retinopathy, and post-surgical recovery. Here is the part that matters most: it is not FDA-approved, and the evidence for Khavinson-style retinal bioregulators is heavily concentrated within Khavinson's own institute and clinical program, not replicated by independent international groups to modern standards. The related pharmaceutical Retinalamin is registered for clinical use in Russia, but that registration reflects the Russian system, not FDA or EMA review. There are essentially no rigorous, independent, placebo-controlled trials specific to Normoftal itself in mainstream literature. Treat the marketed eye-health benefits as unproven claims, and treat confidence in this compound as low. |
Frequently Asked Questions: Cerebrolysin vs Normoftal
What is the difference between Cerebrolysin and Normoftal?
Cerebrolysin is a cognitive peptide that cerebrolysin is not a single peptide but a mixture: a preparation of small peptides and free amino acids made by enzymatically breaking down purified porcine (pig) brain protein, manufactured by ever neuro pharma in austria. it is given by injection and is approved as a prescription drug in dozens of countries for stroke, traumatic brain injury, and dementia, but it is not fda-approved in the united states. despite decades of use abroad, the human evidence remains genuinely contested. Normoftal is a cognitive peptide that normoftal is an obscure russian eye supplement from the khavinson 'peptide bioregulator' tradition, sold as short peptides meant to support the retina. be clear-eyed about this one: it is marketed as a dietary supplement, not an approved drug, and the evidence behind it is thin and comes almost entirely from one research lineage. we keep the claims minimal on purpose. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Cerebrolysin or Normoftal?
Neither is universally "better" - the choice depends on your specific goals. Cerebrolysin is typically used for cognitive purposes, while Normoftal is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Cerebrolysin and Normoftal be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Cerebrolysin and Normoftal together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.